Catalog Products » Antibodies » MonoRab™ Rabbit Monoclonal Antibody Product » MonoRab™ Anti-Obinutuzumab Antibody (169F10) [Biotin], mAb, Rabbit

MonoRab™ Anti-Obinutuzumab Antibody (169F10) [Biotin], mAb, Rabbit

*This product has been discontinued!*
The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01966-40, MonoRab Anti-Obinutuzumab Antibody (8G12), mAb, Rabbit.
A01968
Ask us a question
Overview
Specificity The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01966-40, MonoRab Anti-Obinutuzumab Antibody (8G12), mAb, Rabbit.
Host Species Rabbit
Immunogen Obinutuzumab
Conjugate Biotin

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.01-0.1 µg/ml

Properties
Form Lyophilized
Storage Buffer lyophilized with PBS, pH 7.4, containing 1% BSA and 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
Purification Protein A affinity column
Isotype Rabbit IgG
Clonality Monoclonal
Clone ID 169F10
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Background
Target Background Obinutuzumab (Gazyva) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of chronic lymphocytic leukemia and follicular lymphoma. It binds to a unique conformation epitope on CD20 protein, which partially overlaps with the section recognized by rituximab. When Obinutuzumab binds to CD20 on B cells, it makes these cells to be destroyed by the adaptive immune system. GenScript MonoRab™ Anti-Obinutuzumab Antibody (169F10), mAb, Rabbit is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a rabbit immunized with Obinutuzumab.
Synonyms Rabbit monoclonal to Gazyva

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


feedback

Do you like the current new website?

Hate

Dislike

Neutral

Like

Love

*